Mineralocorticoid receptor blockade protects the kidneys but does not affect inverted blood pressure rhythm in hypertensive transgenic (mRen-2)27 rats

Mol Cell Endocrinol. 2023 Jul 15:572:111967. doi: 10.1016/j.mce.2023.111967. Epub 2023 May 18.

Abstract

Aldosterone regulates blood pressure (BP) through water and sodium balance. In our study, we studied if continuous treatment with a mineralocorticoid receptor antagonist, spironolactone (30 mg/kg/day) for 20 days can: 1) attenuate hypertension development and restore inverted 24-h BP rhythm in hypertensive transgenic (mRen-2)27 rats (TGR) measured by telemetry; 2) improve function of the kidneys and heart; 3) be protective against high salt load (1% in water) by mitigating oxidative injury and improving kidney function. Spironolactone decreased albuminuria and 8-isoprostane in normal and salt load conditions in BP-independent effects. Salt load increased BP, impaired autonomic balance, suppressed plasma aldosterone level and increased natriuresis, albuminuria and oxidative injury in TGR. Spironolactone did not restore the inverted 24-h rhythm of BP in TGR, therefore, mineralocorticoids are not crucial in regulation of BP daily profile. Spironolactone improved kidney function, decreased oxidative stress and was protective against high salt load in the BP-independent manner.

Keywords: Blood pressure; Kidney function; Salt load; Spironolactone; TGR (mRen-2)27 rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuminuria
  • Aldosterone* / pharmacology
  • Animals
  • Animals, Genetically Modified
  • Blood Pressure
  • Hypertension*
  • Kidney
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Rats
  • Receptors, Mineralocorticoid / genetics
  • Spironolactone / pharmacology
  • Water / pharmacology

Substances

  • Aldosterone
  • Receptors, Mineralocorticoid
  • Spironolactone
  • Water
  • Mineralocorticoid Receptor Antagonists